AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2018
Aug 3, 2018
29828_dirs_2018-08-03_4ffdca0b-c99a-418e-862f-09c73485adbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-08-01
Reporting Person: MARTIN JOHN C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-01 | Common Stock | M | 50000 | $23.60 | Acquired | 3067762 | Direct |
| 2018-08-01 | Common Stock | S | 50000 | $77.853 | Disposed | 3017762 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-01 | Non-qualified Stock Option (Right to Buy) | $23.60 | M | 50000 | Disposed | 2019-01-21 | Common Stock (50000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $77.38 to $78.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.